Janne Møller

ORCID: 0000-0003-1839-3669
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Rheumatoid Arthritis Research and Therapies
  • Occupational exposure and asthma
  • Inflammatory Myopathies and Dermatomyositis
  • Systemic Sclerosis and Related Diseases
  • Medical Imaging and Pathology Studies
  • Child and Adolescent Health
  • Tuberculosis Research and Epidemiology
  • Eosinophilic Disorders and Syndromes
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational and environmental lung diseases
  • Neurology and Historical Studies
  • Bacillus and Francisella bacterial research
  • Inhalation and Respiratory Drug Delivery
  • Atomic and Subatomic Physics Research
  • Tracheal and airway disorders
  • Airway Management and Intubation Techniques
  • Tumors and Oncological Cases
  • Microtubule and mitosis dynamics
  • Transplantation: Methods and Outcomes
  • Drug-Induced Adverse Reactions
  • Sarcoma Diagnosis and Treatment
  • Global Health and Epidemiology
  • Pulmonary Hypertension Research and Treatments

Aarhus University Hospital
2010-2024

Aarhus University
2024

Holbæk Sygehus
2022

Webster Groves Nature Study Society
2009

The clinical manifestations of sarcoidosis vary widely, depending on the intensity inflammation and organ systems affected. Hence, patients may suffer from a great variety symptoms. aim this study was to compare self-reported burden in Denmark, Germany Netherlands, especially prevalence fatigue small fiber neuropathy (SFN)-related symptoms, as well differences treatment strategies.A cross-sectional web-based anonymous survey about complaints conducted among patients. Patients were invited...

10.1007/s00408-019-00206-7 article EN cc-by Lung 2019-02-16

Hypersensitivity pneumonitis (HP) is a complex pulmonary disorder mediated by the immune system and caused various inhaled antigens against which subject has previously been sensitized. In about 50% of cases, antigen not identified. Identification removal eliciting important for prognosis. We report two cases HP molds atypical mycobacteria isolated from wind instruments. present first case bassoon playing another in trombone. fungi bacteria instruments may be much more common than thought....

10.1080/20018525.2017.1351268 article EN cc-by European Clinical Respiratory Journal 2017-01-01

Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with median survival of 3-5 years. The aim the present study was to evaluate severity and in patients diagnosed IPF era antifibrotic therapies compared an earlier cohort.We identified all fibrotic ILD hospital electronic case record system between 2011 2016, reviewed each order identify incident IPF. We used GAP-index compare mortality previous findings at our center 2003 2009.260 were 2016. Mean age 72.6 years,...

10.1080/20018525.2020.1807682 article EN cc-by European Clinical Respiratory Journal 2020-01-01

Two cases: A 66-year-old woman was referred to the hospital due dyspnoea and cough. Seven months prior referral, patient had choked on a chunk of nut grain-filled bread. She daily cough dyspnoea. The convinced an airway foreign body she contacted her general practitioner emergency service several times; they all found this unlikely. Fibre optic bronchoscopy revealed two obstructing nut-like bodies in right upper lower lobe, respectively. 77-year-old man with sarcoidosis developed increased...

10.1136/bcr-2014-209240 article EN BMJ Case Reports 2015-05-22

10.1111/j.1600-0404.1966.tb01198.x article EN Acta Neurologica Scandinavica 2009-01-29

Obstetric Anesthesia Digest: September 2010 - Volume 30 Issue 3 p 176 doi: 10.1097/01.aoa.0000386842.81244.28

10.1097/01.aoa.0000386842.81244.28 article EN Obstetric Anesthesia Digest 2010-08-25

In this review, we discuss a new definition and treatment options of allergic alveolitis (AA). AA is an immune-mediated interstitial lung disease triggered by inhaled antigens, it defined as non-fibrotic (inflammatory) and/or fibrotic, diagnosis relies on multidisciplinary approach using clinical, radiological sometimes histological assessments. Treatment involves early antigen elimination may include corticosteroids or other immunosuppressants. Prognosis varies from reversible inflammation...

10.61409/v11230705 article EN cc-by-nc-nd Ugeskrift for Læger 2024-04-01

Background Quality of life is impaired in patients with sarcoidosis. The King's Sarcoidosis Questionnaire (KSQ) a brief questionnaire assessing health-related quality sarcoidosis, comprising subdomains General Health Status (GHS), Lung, Medication, Skin and Eyes. aim this study was to enhance the validation KSQ, incorporating longitudinal known-groups validity cohort mild Methods KSQ linguistically validated according guidelines. Patients sarcoidosis completed other questionnaires at...

10.1183/23120541.00160-2024 article EN cc-by-nc ERJ Open Research 2024-06-06

<b>Introduction:</b> Bone health in sarcoidosis can be altered due to inflammation, bone involvement or treatment. <b>Aim:</b> To investigate change BMD over time Danish patients with sarcoidosis. <b>Methods:</b> In 117 sarcoidosis, was measured twice 12 months interval. T-scores and scores were compared between glucocorticoid treated non-treated patients. <b>Results:</b> Mean age of the 47 years, 57% men, 35% prednisolone 16% bisphosphonate. increased time, Table 1. No difference mean...

10.1183/13993003.congress-2023.pa2228 article EN 2023-09-09

<b>Background:</b> Fatique is reported in 39% of patients with idiopathic pulmonary fibrosis (IPF) and also a registered side effect pirfenidone. The Assessment Scale (FAS) was developed for assessment fatique sarcoidosis has only been used little IPF. aim the present study to determine change FAS measured before after initiation treatment pirfenidone or nintedanib. <b>Method:</b> Between April 2017 January 2018, all incident IPF starting antifibrotic were asked complete before, 4 weeks 3...

10.1183/13993003.congress-2018.pa5237 article EN 12.01 - Idiopathic interstitial pneumonias 2018-09-15

Idiopathic Non-Specific Interstitial Pneumonia (iNSIP) is a rare interstitial lung disease, diagnosed, by definition, on the basis of multidisciplinary team discussion (MDD). Association with an autoimmune background has been suggested in iNSIP. To test feasibility conducting multinational MDD to review diagnosis iNSIP cases and estimate emergence connective tissue disease (CTD) during follow-up. Investigators from three expert centers (Denmark, Estonia Norway) met discussed biopsy-proven at...

10.1080/20018525.2021.1933878 article EN cc-by-nc European Clinical Respiratory Journal 2021-01-01

<b>Background:</b> INSIP is a rare interstitial lung disease and diagnosis by definition, demands multidisciplinary team (MDT) discussion. It has been suggested that iNSIP might be associated with an autoimmune background later reveals itself as disease. <b>Aims:</b> Using the MDT approach, we aimed at establishing retrospective, multinational cohort of larger number patients to characterize clinical properties baseline development CTD. A pilot study was done test feasibility above. We...

10.1183/13993003.congress-2016.pa4876 article EN 2016-09-01

Neurosarcoidosis is a rare and serious condition. Rapid diagnosis treatment are crucial to prevent morbidity mortality. When neurological symptoms not present at the time of diagnosis, CNS involvement can be undetected. We case neurosarcoidosis complicating Löfgren's syndrome discus challenges in diagnostics treatment, that encountered.

10.36141/svdld.v40i4.13104 article EN PubMed 2023-12-20
Coming Soon ...